tiprankstipranks
Advertisement
Advertisement

BAYRY Stock Latest News

Bayer upgraded to Buy from Neutral at Rothschild & Co Redburn
The FlyBayer upgraded to Buy from Neutral at Rothschild & Co Redburn
2d ago
Bayer Refreshes Key Larotrectinib Cancer Study, Reinforcing Its Niche Oncology Edge
PremiumCompany Announcements
Bayer Refreshes Key Larotrectinib Cancer Study, Reinforcing Its Niche Oncology Edge
2d ago
BAYRY
SCOTUS weighs blocking suits alleging Roundup causes cancer, WaPo reports
PremiumThe Fly
SCOTUS weighs blocking suits alleging Roundup causes cancer, WaPo reports
3d ago
Midday Fly By: Verizon reports ‘beat and raise,’ Shell to acquire ARC
PremiumThe Fly
Midday Fly By: Verizon reports ‘beat and raise,’ Shell to acquire ARC
3d ago
VZ
WW
Bayer hopes U.S. Supreme Court can rein in Roundup lawsuits, Bloomberg says
PremiumThe Fly
Bayer hopes U.S. Supreme Court can rein in Roundup lawsuits, Bloomberg says
4d ago
The Week That Was, The Week Ahead: Macro and Markets, April 26
PremiumMarket NewsThe Week That Was, The Week Ahead: Macro and Markets, April 26
5d ago
F
O
Bayer’s AskBio to supply commercial-scale drug product for Regenerate-PD
Premium
The Fly
Bayer’s AskBio to supply commercial-scale drug product for Regenerate-PD
10d ago
Bayer’s AskBio to supply commercial-scale drug product for Regenerate-PD
Premium
The Fly
Bayer’s AskBio to supply commercial-scale drug product for Regenerate-PD
10d ago
Bayer’s RELIEF Study Sets the Stage for Real-World Data on Elinzanetant and Menopause Care
PremiumCompany Announcements
Bayer’s RELIEF Study Sets the Stage for Real-World Data on Elinzanetant and Menopause Care
12d ago
BAYRY
Bayer price target raised to EUR 43 from EUR 23 at Deutsche Bank
PremiumThe Fly
Bayer price target raised to EUR 43 from EUR 23 at Deutsche Bank
14d ago
Bayer’s TARA Study: Real‑World Prostate Cancer Data That Could Shape BAYRY’s Outlook
PremiumCompany Announcements
Bayer’s TARA Study: Real‑World Prostate Cancer Data That Could Shape BAYRY’s Outlook
14d ago
BAYRY
Bayer’s FIRST-2.0 China Study: Real-World Kidney Data That Could Matter for BAYRY
PremiumCompany Announcements
Bayer’s FIRST-2.0 China Study: Real-World Kidney Data That Could Matter for BAYRY
16d ago
BAYRY
Bayer upgraded to Hold from Sell at DZ Bank
PremiumThe FlyBayer upgraded to Hold from Sell at DZ Bank
21d ago
Bayer Targets India Hemophilia Market With New Real World Safety Study
Premium
Company Announcements
Bayer Targets India Hemophilia Market With New Real World Safety Study
22d ago
BAYRY
Bayer’s ARDS ICU Study Shines Light on Long-Term Risks and Costs
Premium
Company Announcements
Bayer’s ARDS ICU Study Shines Light on Long-Term Risks and Costs
28d ago
BAYRY
Bayer’s Double-DARE Prostate Cancer Study Builds Real-World Case for Nubeqa
PremiumCompany Announcements
Bayer’s Double-DARE Prostate Cancer Study Builds Real-World Case for Nubeqa
29d ago
BAYRY
Bayer says Europe may need to pay more for medicines, FT reports
PremiumThe Fly
Bayer says Europe may need to pay more for medicines, FT reports
29d ago
Bayer’s ACO-REAL Study: Real-World Data on Acoramidis Could Shape ATTR-CM Market Prospects
PremiumCompany Announcements
Bayer’s ACO-REAL Study: Real-World Data on Acoramidis Could Shape ATTR-CM Market Prospects
1M ago
BAYRY
Bayer appoints Nelson Ambrogio as president of U.S. pharmaceuticals
PremiumThe Fly
Bayer appoints Nelson Ambrogio as president of U.S. pharmaceuticals
1M ago
Bayer upgraded to Outperform from Neutral at Oddo BHF
PremiumThe FlyBayer upgraded to Outperform from Neutral at Oddo BHF
1M ago
Bayer announces Kerendia meets primary endpoint in FIND-CKD study
Premium
The Fly
Bayer announces Kerendia meets primary endpoint in FIND-CKD study
2M ago
Bayer upgraded to Buy from Neutral at UBS
Premium
The Fly
Bayer upgraded to Buy from Neutral at UBS
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >